Table 1.
The functional roles of PRL-3 expression in progression of HCC.
| Characteristics | N (n=124, %) | PRL-3 low expression (n=68, %) | PRL-3 high expression (n=56, %) | P values |
|---|---|---|---|---|
| Age (years) | 0.294 | |||
| ≥60 | 64 (51.6) | 38 (55.9) | 26 (46.4) | |
| <60 | 60 (48.4) | 30 (44.1) | 30 (53.6) | |
| Sex | 0.888 | |||
| Male | 70 (56.5) | 38 (55.9) | 32 (57.1) | |
| Female | 54 (43.5) | 30 (44.1) | 24 (42.9) | |
| Smoking | 0.850 | |||
| Yes | 72 (58.1) | 40 (58.8) | 32 (57.1) | |
| No | 52 (41.9) | 28 (41.2) | 24 (42.9) | |
| Tumor size(cm) | 0.263 | |||
| ≤3 | 60 (48.4) | 36 (52.9) | 24 (42.9) | |
| >3 | 64 (51.6) | 32 (47.1) | 32 (57.1) | |
| Hepatic vascular invasion | 0.019 | |||
| Yes | 48 (38.7) | 20 (29.4) | 28 (50.0) | |
| No | 76 (61.3) | 48 (40.6) | 28 (50.0) | |
| Lymph node metastasis | 0.012 | |||
| Yes | 47 (37.9) | 19 (27.9) | 28 (50.0) | |
| No | 77 (62.1) | 49 (72.1) | 28 (50.0) | |
| TNM stage | 0.001 | |||
| I–II | 74 (59.7) | 50 (73.5) | 24 (42.9) | |
| III–IV | 50 (40.3) | 18 (26.5) | 32 (57.1) |
TNM – tumor node metastasis.